The Medication Administration Stakeholder Group, convened by the National Alliance of State Pharmacy Associations (NASPA) and the College of Psychiatric and Neurologic Pharmacists (CPNP), has developed state policy recommendations for pharmacist administration of medications. These recommendations encompass all non-vaccine medications, and also specifically address the administration of long-acting injectable (LAI) antipsychotic medications, a class of medications that has a clear public health need for increased access.
Stakeholder Group participants included pharmacists and contributors from a variety of backgrounds, including mental health and were selected based on their knowledge and experience with medication administration or pharmacy policy. Participants considered the existing landscape of state laws and regulations, the need for increased patient access, and pharmacist education and training in compiling their recommendations.
NASPA and CPNP would like to thank Janssen for their sponsorship which helped make this work possible.